Showing results (161-170 of 314) with videos related to
Sort By:
Pageof 32
Journal of Pharmaceutical Sciences|July 1, 1991
In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsionsA Rubinstein, Y V Pathak, J Kleinstern, et al.European Journal of Medical Genetics|June 22, 2019
From phenotyping to genotyping - bioinformatics for the busy clinicianA Reches, K Weiss, L Bazak, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1993
Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell lineB Pardo, M A Mena, S Fahn, et al.Brain Research|December 29, 1987
Differential changes in 125I-LSD-labeled 5-HT-2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN): evidence from autoradiographic studiesJ L Cadet, B Kuyatt, S Fahn, et al.Neurology|May 1, 1976
Primary sensory symptoms in parkinsonismS R Snider, S Fahn, W P Isgreen, et al.Journal of Pharmaceutical Sciences|November 1, 1984
Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromideA M Crider, T F Hemdi, M N Hassan, et al.Annals of Neurology|October 1, 1996
Diagnostic guidelines in central nervous system Whipple's diseaseE D Louis, T Lynch, P Kaufmann, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1995
Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body diseaseE D Louis, J E Goldman, J M Powers, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Therapeutic trial of milacemide in patients with myoclonus and other intractable movement disordersM F Gordon, R Diaz-Olivo, A L Hunt, et al.Neurology|September 1, 1975
Normalization of brain serotonin by L-tryptophan in levodopa-treated ratsS Fahn, S Snider, A L Prasad, et al.Pageof 32